MedTrace Logo

Colorectal Cancer: Screening vs. Non-Screening

NCT02727894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 276

Last updated 2019-03-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether colorectal cancer diagnosed by screening (primary screening colonoscopy, colonoscopy after immunochemical based faecal occult blood test) has more favourable clinical-pathological characteristics than colorectal cancer diagnosed for symptoms. We aimed to compare these two groups of patients at the time of diagnosis and confirm the efficiency of the screening programme.

Conditions

Sponsors & Collaborators

  • Private practice at Hluboká nad Vltavou

    collaborator UNKNOWN

  • Klaudian Hospital Mladá Boleslav

    collaborator UNKNOWN

  • Masaryk Hospital Usti nad Labem

    collaborator OTHER

  • Brno University Hospital

    collaborator OTHER

  • Medic Kral Ltd.

    collaborator UNKNOWN

  • Chomutov Hospital

    collaborator UNKNOWN

  • Tomas Bata Hospital, Czech Republic

    collaborator OTHER

  • Military University Hospital, Prague

    collaborator OTHER

  • Frýdek-Místek Hospital

    collaborator UNKNOWN

  • The University Hospital Plzeň

    collaborator UNKNOWN

  • Vitkovice Hospital

    collaborator OTHER

  • Institute for Clinical and Experimental Medicine

    lead OTHER_GOV

Principal Investigators

  • Jan Král, M.D. · Institute for Clinical and Experimental Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02727894 on ClinicalTrials.gov